This kit is designed for the quantitative detection of the Human host cell DNA in intermediate, semi-finished and finished products of various biological products.
This kit adopts the principle of the Taqman probe to quantitatively detect Human residual DNA in samples. The kit is a rapid, specific and reliable device, with the minimum detection limit reaching fg level.
| Specification | 100 Reactions |
Assay range | 3.00×10¹~3.00×10⁵ fg/μL |
Limit of quantitation | 3.00×10¹ fg/μL |
Precision | CV%≤15% |
| Validity period | 18 months |
| Storage conditions | -20℃ |
| LOQ | 30 fg/μL |
| LOD | 3 fg/μL |
| Concentration（fg/μl） | Log Concentration | Ct Value（1） | Ct Value（2） | Ct Value（3） | Ct Mean Value | Recovery rate |
| 3.00E+05 | 5.48 | 23.52 | 23.37 | 23.39 | 23.43 | 88% |
| 3.00E+04 | 4.48 | 26.64 | 26.55 | 26.45 | 26.54 | 111% |
| 3.00E+03 | 3.48 | 30.16 | 30.07 | 30.06 | 30.09 | 105% |
| 3.00E+02 | 2.48 | 33.75 | 33.33 | 33.52 | 33.53 | 107% |
| 3.00E+01 | 1.48 | 38.3 | 36.49 | 36.90 | 37.26 | 90% |
| Amplification efficiency | 94.34% | |||||
Standard curve:
1-805-304-6109 
info@hillgene.com 
English
![[GMP revised] Appendix for “Investigational Drugs (Interim)” issued and taking effect as of July 1!](/uploads/image/20250603/gmp-revised-appendix-for-investigational-drugs-interim-issued-and-taking-effect-as-of-july-1.webp "[GMP revised] Appendix for “Investigational Drugs (Interim)” issued and taking effect as of July 1!")
